Evidence map›Paper›PMID 42163888›Full record

ArticleAmerican journal of cancer research2026

Erratum: SLFN5 influences proliferation and apoptosis by upregulating PTEN transcription via ZEB1 and inhibits the purine metabolic pathway in breast cancer.

Xuefeng Gu, Guoqing Wan, Yue Yang, Yihao Liu, Xintong Yang, Yanjun Zheng, Liying Jiang, Peng Zhang, Dingsheng Liu, Weiming Zhao and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Xuefeng GuShanghai University of Medicine & Health Science Affiliated Zhoupu Hospital Shanghai, P. R. China.
Guoqing WanShanghai University of Medicine & Health Science Affiliated Zhoupu Hospital Shanghai, P. R. China.
Yue YangDepartment of Pathology, Mudanjiang Medical University Mudanjiang, Heilongjiang, P. R. China.
Yihao LiuNHC Key Laboratory of Human Disease Comparative Medicine, Institute of Laboratory Animal Sciences, CAMS&PUMC Beijing, P. R. China.
Xintong YangShanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine & Health Sciences Shanghai, P. R. China.
Yanjun ZhengShanghai University of Medicine & Health Science Affiliated Zhoupu Hospital Shanghai, P. R. China.
Liying JiangShanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine & Health Sciences Shanghai, P. R. China.
Peng ZhangSchool of Clinical Medicine, Shanghai University of Medicine & Health Sciences Shanghai, P. R. China.
Dingsheng LiuShanghai University of Medicine & Health Science Affiliated Zhoupu Hospital Shanghai, P. R. China.
Weiming ZhaoQiqihar Medical University Qiqihar, Heilongjiang, P. R. China.
Gang HuangShanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine & Health Sciences Shanghai, P. R. China.
Changlian LuShanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine & Health Sciences Shanghai, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article on p. 2832 in vol. 10, PMID: 33042620.].

Identifiers

PMID42163888
PMCPMC13184758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.